Tocilizumab for relapsing and remitting giant cell arteritis: a case series

Overview of attention for article published in Journal of Medical Case Reports, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,091 followers.

Tocilizumab for relapsing and remitting giant cell arteritis: a case series - J Med Case Rep https://t.co/7LotZzQMo5

01 Nov 2022

Reply Repost Favourite

11-17-21: London, England: After corticosteroids, Trexall (methotrexate), & other DMARDs had failed, the all-purpose antioxidant, Actemra (tocilizumab), was called in to rescue 16 patients from relapsing-and-remitting giant cell arteritis. Too late f

30 Oct 2022

Reply Repost Favourite

Tocilizumab for relapsing and remitting giant cell arteritis: a case series https://t.co/VvIk5ghp42

27 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.